January 2016 – CROSS SA and CROSS Research SA would like to inform that the two companies decided to proceed with a merger by the incorporation of CROSS SA into CROSS Research SA.
The merger followed a simplified procedure since CROSS SA and CROSS Research SA were both owned by the same shareholder.
The merger was decided with the aim of both simplifying the corporate structure, and primarily to enhance CROss Alliance™ group’s operations in the performance of medium/large size Phase II-III clinical trials.
The merger that will be formally completed by the end of March involved the incorporation of all assets and liabilities of CROSS SA by CROSS Research SA. Therefore CROSS Research SA will replace CROSS SA in all its rights, Client’s obligations and agreements without any interruption.